Enhanced Safety and Efficacy of Oncolytic VSV Therapy by Combination with T Cell Receptor Transgenic T Cells as Carriers-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Enhanced Safety and Efficacy of Oncolytic VSV Therapy by Combination with T Cell Receptor Transgenic T Cells as Carriers

Published:2019-03 Issue: Volume:12 Page:26-40
ISSN:2372-7705
Container-title:Molecular Therapy - Oncolytics
language:en
Short-container-title:Molecular Therapy - Oncolytics

Author:

Melzer Michael Karl,Zeitlinger Lisa,Mall Sabine,Steiger Katja,Schmid Roland M.,Ebert Oliver,Krackhardt Angela,Altomonte Jennifer

Funder

Deutsche Forschungsgesellschaft

Publisher

Elsevier BV

Subject

Pharmacology (medical),Cancer Research,Oncology,Molecular Medicine

Reference47 articles.

1. Tyrosine kinase inhibitors targeting FLT3 in the treatment of acute myeloid leukemia;Chen;Stem Cell Investig.,2017

2. Acute myeloid leukemia, version 3.2017, NCCN Clinical Practice Guidelines in Oncology;O’Donnell;J. Natl. Compr. Canc. Netw.,2017

3. Acute myeloid leukemia;Döhner;N. Engl. J. Med.,2015

4. Immunotherapeutic concepts to target acute myeloid leukemia: focusing on the role of monoclonal antibodies, hypomethylating agents and the leukemic microenvironment;Gbolahan;Int. J. Mol. Sci.,2017

5. Induction chemotherapy versus palliative treatment for acute myeloid leukemia in a consecutive cohort of elderly patients;Colovic;Ann. Hematol.,2012

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing cancer therapy: the integration of oncolytic virus therapy with diverse treatments;Cancer Cell International;2024-07-11

2. Advances in cell-based delivery of oncolytic viruses as therapy for lung cancer;Molecular Therapy: Oncology;2024-03

3. Viral therapy for targeted drug delivery to cancers: Recent advances, clinical and regulatory perspectives;Journal of Drug Delivery Science and Technology;2024-02

4. Advancements and challenges in oncolytic virus therapy for gastrointestinal tumors;Biomedicine & Pharmacotherapy;2023-12

5. CAR T-cell therapy: Reprogramming patient's immune cell to treat cancer;Cellular Signalling;2023-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3